Overview

Study of ALV003 in Healthy Adult Volunteers and Subjects With Well-Controlled Celiac Disease Following a Gluten-Containing Meal

Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
ALV003-0812 is a study of the safety and tolerability of a study drug (ALV003) in healthy adult volunteers and in patients with well-controlled celiac disease, following a meal that contains gluten.
Phase:
Phase 1
Details
Lead Sponsor:
Alvine Pharmaceuticals Inc.